Live Breaking News & Updates on James Breitmeyer

Stay updated with breaking news from James breitmeyer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Oncternal Therapeutics, Inc. (NASDAQ:ONCT) Q1 2024 Earnings Call Transcript

Oncternal Therapeutics, Inc. (NASDAQ:ONCT) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

Carl Byrnes , Salim Yazji , Richard Vincent , Kemp Dolliver , Robert Burns , Jim Breitmeyer , James Breitmeyer , Hartaj Singh , Oncternal Therapeutics Inc , Oppenheimer Company , International Students , Oncternal Therapeutics , Call Transcript May , First Quarter , Chief Financial , Safe Harbor , Private Securities Litigation Reform , Northland Capital , Dangerous Crime Lords , Brookline Capital ,

Oncternal Therapeutics To Participate In Oppenheimer 34Th Annual Healthcare Life Sciences Conference

Oncternal Therapeutics To Participate In Oppenheimer 34Th Annual Healthcare Life Sciences Conference
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

Richard Vincent , Corey Davis , James Breitmeyer , Oppenheimer Co , Oncternal Therapeutics Inc , Healthcare Life Sciences Conference , Chief Executive Officer , Annual Healthcare Life Sciences Conference , Click Here , Receptor Tyrosine Kinase Like Orphan ,

Oncternal Therapeutics to Participate in Oppenheimer 34th Annual Healthcare Life Sciences Conference

Oncternal Therapeutics to Participate in Oppenheimer 34th Annual Healthcare Life Sciences Conference
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

James Breitmeyer , Richard Vincent , Corey Davis , Oncternal Therapeutics Inc , Healthcare Life Sciences Conference , Oppenheimer Co , Annual Healthcare Life Sciences , Chief Executive Officer , Annual Healthcare Life Sciences Conference , Receptor Tyrosine Kinase Like Orphan ,

Oncternal Therapeutics, Inc. (NASDAQ:ONCT) Q3 2023 Earnings Call Transcript

Oncternal Therapeutics, Inc. (NASDAQ:ONCT) Q3 2023 Earnings Call Transcript November 9, 2023 Oncternal Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.17 EPS, expectations were $-0.15. Operator: Greetings and welcome to Oncternal Therapeutics third-quarter 2023 financial results conference call. [Operator Instructions]. As a reminder, this conference is being recorded. I would now like to […] ....

City Of , United Kingdom , Salim Yazji , James Breitmeyer , Carl Byrnes , Matthew Smith , Evan Yu , Fred Hutch , Richard Vincent , Professor Johann De Bono , Mass General , Northland Capital , Nanotechnology Stocks To Buy , Performing Dividend , Oncternal Therapeutics , R James Breitmeyer , Salim Yazji , Prostate Cancer , Perator Instructions , Forward Looking Statements , Dose Escalation Study , James Breitmeyer , Financial Results Conference ,